TESARO (TSRO) Announces FDA Approval of VARUBI for Delayed Nausea and Vomiting Associated Chemo
Tweet Send to a Friend
TESARO, Inc. (NASDAQ: TSRO) announced that the U.S. Food and Drug Administration (FDA) has approved VARUBI® (rolapitant) IV in combination ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
